In 2023, the import value of pharmaceutical products to the UK stood at approximately 35.214 billion US Dollars. From 2024 to 2028, the forecasted data shows a steady increase in the import value, starting at 35.829 billion US Dollars in 2024 and reaching 38.258 billion US Dollars in 2028.
Analysing the year-on-year percentage variation:
- 2024 shows an increase of 1.75% compared to 2023.
- 2025 sees a year-on-year increase of 1.75% compared to 2024.
- 2026 marks a 1.68% increase compared to 2025.
- 2027 indicates a 1.62% increase compared to 2026.
- 2028 exhibits a 1.56% increase compared to 2027.
The Compound Annual Growth Rate (CAGR) over the forecasted period from 2024 to 2028 is approximately 1.65%, suggesting a consistent average annual growth in imports.
Future trends to watch for include potential impacts of Brexit-related regulations, advances in pharmaceutical technologies, shifts in global supply chains, and health crises which might influence the demand and regulatory environment for pharmaceutical imports to the UK.
